|Articles|September 15, 2016
Bracket Randomizes First Patient Using PBD Tech
Bracket has randomized its first patient using Precision Block Design (PBD) technology fully integrated into its clinical IRT platform and its mobile application.
Advertisement
Bracket has randomized its first patient using Precision Block Design (PBD) technology fully integrated into its clinical IRT platform and its mobile application. This technology was created for sponsors who want or need to utilize block pattern distribution in their randomization lists.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad
2
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
3
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
4
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
5